A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomas.

A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomas. Cancer. 2013 May 01; 119(9):1683-9.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Epothilones
Female
Humans
Lymphoma, Non-Hodgkin
Male
Middle Aged
Recurrence

authors with profiles

Koen Van Besien
Justin P. Kline
Theodore Karrison